Navigation Links
Abpro Expands Senior Leadership Team and Announces Adam Mostafa as Chief Financial Officer

WOBURN, Massachusetts, January 31, 2017 /PRNewswire/ --

Abpro, a leading therapeutic antibody company targeting human disease and at the forefront of synthetic biology, today announced the expansion of its senior leadership team with Adam Mostafa as Chief Financial Officer.

"I am pleased to be working with Adam as Abpro's Chief Financial Officer," said Chairman and Chief Executive Officer Ian Chan. Adam brings broad and proven healthcare corporate finance expertise to Abpro, and we look forward to utilizing his experience as we continue to pursue challenging therapeutic targets and bring our emerging product pipeline into the clinic through our DiversImmuneTM platform. I am confident that Adam will play a critical role in helping us execute our strategic vision for Abpro's growth."

Mr. Mostafa has worked on numerous life sciences transactions including as Managing Director in the Healthcare Investment Banking group at Cantor Fitzgerald. Prior to Cantor, Mr. Mostafa was with Needham & Company, CRT Capital Group and Citigroup as a member of their Healthcare Investment Banking groups where he worked on life sciences IPOs, public and private financings and M&A transactions. Mr. Mostafa also has institutional investing experience, having spent a number of years at AQR Capital Management, and has a Bachelor of Arts in Economics from Brown University. 

"Abpro has immense potential to leverage its DiversImmuneTM platform to generate antibodies against difficult human genome targets," said Adam Mostafa. "I am delighted to be a part of such an innovative company at an exciting time and to help further its growth as a member of the senior management team."

About Abpro

Abpro is a leading therapeutic antibody company targeting human disease. Through its core technology, the DiversImmuneTM platform, Abpro leverages synthetic biology and immunology to generate therapeutic antibodies against novel and challenging targets. Abpro partners with leading biotechnology and pharmaceutical companies globally and has a broad pipeline of programs in immuno-oncology, ophthalmology and inflammatory disease. For more information, visit

Abpro Media Contact:
Vivian Chen, Citigate Dewe Rogerson
+1 (347) 481-3711

Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Lehigh Valley Expands Fleet of Superbug-Slaying Robots
2. Avillion Expands Leadership Team with Appointment of Ramani Varanasi as Chief Business Officer
3. Fortune 500 Pharmaceutical Company Expands Use of inContact Cloud Contact Center Software Across Multiple Divisions
4. BioDrain Breaks into National Network of Ambulatory Surgical Centers and Expands Installations of its STREAMWAY System throughout the U.S.
5. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
6. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
7. NextDocs Expands Customer Roster by More Than 10 Percent
8. Sotera Wireless Expands Board Of Directors
9. Novira Therapeutics Expands Management Team with Appointment of Klaus Klumpp, Ph.D., the Former Global Head of Roches Virology Discovery Initiatives, as Vice President Discovery Research
10. Senior Home Care Expands Home Health Telemonitoring into Spring Hill, Fla.
11. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
Post Your Comments:
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
Breaking Medicine News(10 mins):